Impact of bcr-abl1 transcript type on response, treatment-free remission rate and survival in chronic myeloid leukemia patients treated with imatinib

  1. Marcé, S.
  2. Xicoy, B.
  3. García, O.
  4. Cabezón, M.
  5. Estrada, N.
  6. Vélez, P.
  7. Boqué, C.
  8. Sagüés, M.
  9. Angona, A.
  10. Teruel-Montoya, R.
  11. Ferrer-Marín, F.
  12. Amat, P.
  13. Hernández-Boluda, J.C.
  14. Ibarra, M.M.
  15. Anguita, E.
  16. Cortés, M.
  17. Fernández-Ruiz, A.
  18. Fontanals, S.
  19. Zamora, L.
Zeitschrift:
Journal of Clinical Medicine

ISSN: 2077-0383

Datum der Publikation: 2021

Ausgabe: 10

Nummer: 14

Art: Artikel

DOI: 10.3390/JCM10143146 GOOGLE SCHOLAR lock_openOpen Access editor